SOURCE: Syneron Medical Ltd.

Syneron Medical Ltd.

May 30, 2012 10:00 ET

Syneron to Participate in Two Upcoming Investor Conferences

YOKNEAM, ISRAEL--(Marketwire - May 30, 2012) - Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that Louis P. Scafuri, Chief Executive Officer, and Asaf Alperovitz, Chief Financial Officer, are scheduled to participate at two upcoming investor conferences.

The first conference is the Leerink Swann Management Access Day in Boston. This conference will allow institutional investors to meet with Syneron but does not include a formal presentation.

Conference: Leerink Swann Management Access Day
Date: Thursday, May 31, 2012
Syneron Participant: Louis P. Scafuri, Chief Executive Officer

The second conference is the Jefferies 2012 Global Healthcare Conference in New York.

Conference: Jefferies 2012 Global Healthcare Conference
Date and Time: 10:30 a.m. ET on Thursday, June 7, 2012
Syneron Participant: Asaf Alperovitz, Chief Financial Officer

The Jefferies conference presentation will be webcast live over the Internet and can be accessed through the Investor Relations section on Syneron's website at www.syneron.com. Please go to the website a few minutes early, as it may be necessary to download audio software to hear the presentation.

About Syneron Medical Ltd.
Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The Company markets, services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

Contact Information

  • Contacts:

    Asaf Alperovitz
    Chief Financial Officer
    + 972 73 244 2283
    Email: Email Contact

    Zack Kubow
    The Ruth Group
    646-536-7020
    Email: Email Contact